Organigram to Report Q1 Fiscal 2024 Results on Feb 13

TL;DR

**Organigram is dropping Q1 earnings on Feb 13, get ready for potential stock volatility.**

AI Summary

Organigram Holdings Inc. filed a 6-K on February 7, 2024, announcing it will report its First Quarter Fiscal 2024 financial results on February 13, 2024. The report will cover the period ending December 31, 2023. This matters to investors because the upcoming earnings report will provide crucial insights into the company's recent financial performance, including revenue, expenses, and profitability, which can significantly impact the stock price.

Why It Matters

This filing signals an upcoming earnings report, which is a major catalyst for stock movement as it reveals the company's financial health and future outlook.

Risk Assessment

Risk Level: medium — Earnings reports often lead to significant stock price fluctuations, making this a medium-risk event for investors.

Analyst Insight

A smart investor would mark February 13, 2024, on their calendar and prepare to analyze Organigram's Q1 Fiscal 2024 results for potential trading opportunities or to reassess their long-term investment thesis.

Key Players & Entities

• ORGANIGRAM HOLDINGS INC. (company) — the registrant filing the 6-K
• Greg Guyatt (person) — Chief Financial Officer who signed the 6-K
• February 7, 2024 (date) — date of the 6-K filing and press release
• February 13, 2024 (date) — date Organigram will report Q1 Fiscal 2024 results
• December 31, 2023 (date) — end of the First Quarter Fiscal 2024 period

Forward-Looking Statements

• Organigram's stock price will experience increased volatility around February 13, 2024. (ORGANIGRAM HOLDINGS INC.) — high confidence, target: 2024-02-13
• The upcoming earnings report will provide key insights into the company's financial health for the quarter ending December 31, 2023. (ORGANIGRAM HOLDINGS INC.) — high confidence, target: 2024-02-13

FAQ

Filing Documents

• a53893202.htm (6-K) — 6KB
• a53893202ex99_1.htm (EX-99.1) — 7KB
• 0001157523-24-000180.txt ( ) — 14KB

From the Filing

HOLDINGS INC. 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [ X ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] SUBMITTED HEREWITH Exhibits 99.1 Press Release dated February 7, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ORGANIGRAM HOLDINGS INC. /s/ Greg Guyatt Greg Guyatt Chief Financial Officer Date: February 7, 2024

View Full Filing

View this 6-K filing on SEC EDGAR